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CD72-Deficient Mice Reveal Nonredundant Roles
of CD72 in B Cell Development and Activation
or to anti-IgM and synergizes with IL-1 in the induction
of B cell proliferation (Snow et al., 1986; Yakura et al.,
1986; Laurindo et al., 1987). In addition, mouse anti-
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Division of Immunology and Rheumatology CD72 causes a modest increase of class II major histo-
compatibility complex (MHC) gene expression (Polla et²Department of Genetics
Stanford University School of Medicine al., 1988; Subbarao et al., 1988) on splenic B cells.
In other systems, however, inhibitory effects haveStanford, California 94305
been observed in response to CD72 cross-linking. Addi-
tion of anti-CD72 inhibits the primary antibody response
to T-dependent antigens, although it does not affectSummary
responses to T-independent antigens (Yakura et al.,
1981; Subbarao and Mosier, 1984). Anti-CD72 alsoCD72, a B cell surface protein of the C-type lectin
superfamily, recruits the tyrosine phosphatase SHP-1 strongly inhibits LPS and IL-4 initiated IgG1 induction
(Yakura et al., 1988). Furthermore, anti-CD72 mAb treat-through its ITIM motif(s). Using CD72-deficient (CD722/2)
mice, we demonstrate that CD72 is a nonredundant ment can partially rescue mouse splenic B cells from
apoptosis induction by surface immunoglobulin (sIg)regulator of B cell development. In the bone marrow
of CD722/2 mice, there was a reduction in the number hyper-cross-linking (Nomura et al., 1996).
Recent signaling studies on CD72 might explain theseof mature recirculating B cells and an accumulation
of pre-B cells. In the periphery of CD722/2 mice, there observed negative regulatory effects of anti-CD72. The
cytoplasmic domain of CD72 contains two immunore-were fewer mature B-2 cells and more B-1 cells. In
addition, CD72 is a negative regulator of B cell activa- ceptor tyrosine-based inhibitory motifs (ITIM). Adachi et
al. (1998) showed that cross-linking of the BCR en-tion, as CD722/2 B cells were hyperproliferative in re-
sponse to various stimuli and showed enhanced kinet- hances both tyrosine phosphorylation of CD72 and as-
sociation of CD72 with the protein tyrosine phosphataseics in their intracellular Ca21 response following IgM
cross-linking. SHP-1 in the WEHI-231 B cell line. Thus, CD72 might
negatively regulate BCR signaling by recruiting SHP-1,
a negative regulator of BCR signaling (Cyster and Good-Introduction
now, 1995). Furthermore, Wu et al. (1998) demonstrated
that CD72 is an in vivo substrate of SHP-1 in B cells.The development and function of B lymphocytes are
They showed that preligation of CD72 with anti-CD72critically controlled by the strength and quality of signals
mAb attenuates BCR-induced growth arrest/apoptosistransmitted through the B cell antigen receptors (BCR)
signals in primary immature and mature B cells or B celland positive and negative signals delivered by additional
lines and demonstrated a strong correlation betweencell surface molecules, often called coreceptors. The
tyrosine phosphorylation of CD72 and BCR-inducedproperties of the antigen, as well as the nature of core-
growth arrest/apoptosis. Wu et al. (1998) hypothesizedceptor ligation, partially influenced by the microenviron-
that tyrosine-phosphorylated CD72 transmits signals forment in which the B cell receives its signals, determine
BCR-induced apoptosis and that SHP-1 dephosphory-the cell fate of the B cell during positive and negative
lates CD72 and reverses the BCR-mediated apoptoticselection, maturation, and functional activation.
signal.CD72, a 45 kDa type II transmembrane glycoprotein
On the other hand, several biochemical studies sup-and a member of the calcium-dependent lectin super-
port a positive signaling role for anti-CD72. Inositol 1,4,5-family, is one such coreceptor (Nakayama et al., 1989).
triphosphate (IP3) and Ca21 appear to be important inIt is expressed as a disulfide-linked homodimer on all
the signal transduction pathway of CD72. Mouse anti-B cells but not on terminally differentiated plasma cells.
CD72 weakly induces phosphatidyl inositol turnoverIn some mouse strains, CD72 is also expressed at low
(Grupp et al., 1987) and induces an early increase inlevels on subpopulations of T cells (Robinson et al.,
[Ca21]i (Subbarao et al., 1988; Pezzutto et al., 1990).1997).
Protein tyrosine phosphorylation also appears to be in-The in vivo role of CD72 during B cell development and
volved in the CD72 signaling pathway. Venkataramanactivation has not been studied. However, accumulating
et al. (1998b) showed that anti-CD72 induces tyrosineevidence from in vitro studies suggests that CD72 is an
phosphorylation of a variety of proteins in mouse splenicimportant costimulatory molecule for B cell activation.
B cells, including phospholipase C-g2 and CD19, andEngagement of CD72 by monoclonal antibodies (mAb)
activates Lyn, Blk, and Btk kinases. In addition, CD72can transform a subset of small resting B cells into
ligation induces transient association of CD72 withblast cells and induce proliferation of both resting and
CD19 (Venkataraman et al., 1998a), which is a positiveactivated B cells (Subbarao and Mosier, 1982, 1984;
regulator of BCR signaling (Engel et al., 1995; RickertYakura et al., 1986). Engagement of mouse CD72 en-
et al., 1995; Sato et al., 1995, 1996b). CD19 plays ahances the B cell proliferative response either to IL-4
critical role in B-1 cell development and is necessary
for optimal induction of T cell±independent responses³ To whom correspondence should be addressed (e-mail: jrparnes@
leland.stanford.edu). (Rickert et al., 1995; Sato et al., 1995, 1996b).
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Figure 1. Generation of CD722/2 Mice
(A) CD72 targeting strategy: gene structure
of wild-type CD72b allele (top), CD72 targeting
construct (middle), and the resultant CD72
mutant allele (bottom). The intron/exon struc-
ture of the 14.2 kb CD72 clone from 129 mice
is derived from CD72a allele (Ying et al., 1995).
Exons encoding 59 or 39 untranslated se-
quences are shown as open boxes, and ex-
ons encoding coding sequences are shown
by closed boxes. The 2.1 kb fragment con-
taining exons I to IV was replaced with the
pGK-MC1-neo cassette from pPNT (Tybu-
lewicz et al., 1991).
(B) Southern blot analysis. To assess the ge-
notype of mice (wild-type [W]; heterozygous
[H]; homozygous mutants [M]), cDNA corre-
sponding to exons V to VIII was used as
a probe for Southern analysis of EcoRI-
digested mouse genomic DNA. The 8.5 kb
EcoRI fragment represents the wild-type
CD72 allele, and the 5.5 kb fragment depicts
the targeted allele. Positions of EcoRI sites
are shown in (A). The presence of CD72-tar-
geted allele was also determined by PCR us-
ing primers as indicated in (A).
(C) Splenocytes from CD721/1 (bold line),
CD721/2 (thin line), and CD722/2 (shaded
area) mice were stained for CD72 surface ex-
pression with anti-CD72 mAb (K10.6) specific
for both CD72a and CD72b.
Taken together, a number of functional and biochemi- Impaired B Cell Development in CD722/2 Mice
B cell development in the bone marrow of adult 8- tocal studies in vitro indicate that ligation of CD72 by its
mAb leads to multiple effects upon B cell signaling. In 12-week-old CD722/2 mice and their littermate controls
was analyzed by flow cytometry as described (Hardy etorder to begin to unravel the mechanisms of these in
vitro effects of anti-CD72 mAb and particularly to eluci- al., 1991). Total numbers of bone marrow cells recovered
from one femur and one tibia of CD722/2 and wild-typedate the function of CD72 during B cell development
and activation in vivo, we generated CD722/2 mice by mice were comparable. B220loCD431 B cells, containing
the earliest stages of B cell development (pre-pro-B,targeted gene inactivation. Here, we demonstrate that
CD72 plays a nonredundant role in B cell development fraction A; pro-B, fraction B; and late pro-B, fraction C,
Figure 2) were present at normal numbers in the mutantin vivo and negatively regulates responsiveness of B cells.
mice. However, the later stages of B cell development
were altered. Although the numbers of B2201CD432 BResults
cells from mutant and wild-type mice were comparable,
there was a significant decrease in the number of matureGeneration of CD722/2 Mice
A 14.2 kb CD72 genomic clone was isolated from a 129/ IgM1IgD1 B cells (fraction F, Figure 2) and an increase
in the number of IgM2IgD2 pre-B cells (fraction D, FigureSV/EV mouse genomic library (Stratagene) with probes
derived from the CD72 cDNA sequence. The targeting 2). The number of IgM1IgD2 immature B cells (fraction
E, Figure 2) was minimally affected in CD722/2 mice.vector was constructed by removing a 2.1 kb DNA frag-
ment including the CD72 minimal promoter and se- The decreased ratios of immature to pre-B cells and
mature to immature B cells suggest that CD72 may bequence encoding the cytoplasmic and transmembrane
domains to ensure disruption of CD72 protein expres- important for the efficient transitions from pre-B to im-
mature B cells and from immature to mature B cellssion (Figure 1A). Transfection of the embryonic stem
(ES) cell line E14.1 (kindly provided by Dr. Richard Mur- during development.
ray, DNAX Research Institute) resulted in two clones
carrying one copy of the homologously recombined Alterations in Peripheral B Cell Pools
of CD722/2 MiceCD72 mutant allele as demonstrated by Southern blot
and PCR analysis of genomic DNA from ES cell clones. Total numbers of cells from spleen, peripheral lymph
nodes, and Peyer's patches of 8- to 12-week-old CD722/2Standard blastocyst injection techniques were used to
generate chimeric mice from CD72 mutant ES cells. and wild-type mice were comparable. However, the total
number of splenic B cells (B2201) in adult CD722/2 miceGermline transmission of the CD72 targeted allele was
assessed by Southern blot analysis (Figure 1B). Cell was decreased by 24 6 11% compared to wild-type
controls (Figure 3A). The mutant mice also had de-surface staining of spleen cells confirmed the lack of
CD72 expression in homozygous mutants and reduced creased numbers of B cells in lymph nodes (32 6 12%
decrease) and Peyer's patches (20 6 10% decrease)expression of CD72 in heterozygous mutants compared
to wild-type controls (Figure 1C). (Figure 3A).
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Increased Numbers of IgM2IgD2 B Cells in Peyer's
Patches and Lymph Nodes of CD722/2 Mice
Analysis of Peyer's patches and mesenteric lymph
nodes from adult CD722/2 mice revealed an increase in
IgM2IgD2 B cells in these tissues compared to wild-type
controls (Figures 3D and 3E). A comparable frequency of
these IgM2IgD2 B cells in both types of mice stained
highly with peanut agglutinin (Figures 3D and 3E) and
expressed high levels of Fas antigen (data not shown),
therefore suggesting that CD722/2 mice have increased
numbers of B cells with the phenotypic characteristics
of germinal center cells in Peyer's patches and lymph
nodes (Rose et al., 1980; Butcher et al., 1982; Smith et
al., 1995). Consistent with this, there was an increase
in the number (but not percentage) of IgA-expressing
cells in both lymph nodes and Peyer's patches (Figures
3E and 3D). This increase in the number of IgM2IgD2
cells, including germinal center B cells and isotype
switched B cells in CD722/2 mice, suggests that CD72
regulates the levels of B cell activation in vivo. Consis-
tent with this, Percoll gradient purification of wild-type
and mutant B cells showed that mutant mice had ap-
proximately half the number of resting, high buoyant
density splenic B cells (60%±70% Percoll gradient inter-
face) and about twice the number of activated, low buoy-
ant density B cells (50%±60% Percoll gradient interface),
further indicating that the absence of CD72 expression
increases the number of activated B cells in vivo.
Delayed B Cell Development and Maturation
Figure 2. Impaired Early B Cell Development in the Bone Marrow in Young CD722/2 Mice
of CD722/2 Mice To further study the role of CD72 during B cell matura-
B cell development in the bone marrow was analyzed by eight- tion in the periphery, we analyzed B cell develop-
color FACS according to Hardy et al. (1991). Shown at the top are ment in young mice. Consistent with the data from adult
representative 5% probability contour plots of total bone marrow mice, 3- to 5-week-old CD722/2 mice showed a delay
cells from adult CD72 wild-type (1/1) and mutant (2/2) mice. Com-
in B cell maturation. Significantly increased numbers ofparable numbers of bone marrow cells were recovered from one
immature IgMhiB220lo and reduced numbers of maturefemur and one tibia of wild-type and CD722/2 mice. B2201CD431
pro-B cells and B2201CD432 cells including pre-B, immature, and IgMintB220hi cells were found in spleens of young
mature B cells were gated for further analysis of surface expression CD722/2 mice (Figure 4A). Flow cytometric analyses
of BP-1 versus HSA and IgD versus IgM, respectively. Gates are confirmed that the majority of IgMhiB220lo splenic cells
indicated by boxes, and percent of gated cells of total cells within were immature B cells, since they were IgD2/lo, CD232,
the plot is indicated.
CD22lo, and HSAhi (data not shown). The IgMintB220hi
splenic cells were IgDhi, CD22hi, HSAlo and were therefore
mature B cells (data not shown). Three- to five-week-oldCD722/2 mice had a 38 6 11% reduction in IgMintCD231
CD722/2 mice also had significantly decreased numbersmature long-lived follicular B cells (Figures 3A and
(53 6 15%) of mature CD231 follicular B cells in the3B) in the spleen compared to wild-type control mice.
spleen (Figure 4A) and decreased numbers of B cells inIn contrast, CD722/2 mice had normal or increased
lymph nodes (data not shown).numbers of other B cell populations in the spleen. In
In summary, the absence of CD72 led to a delay ratherparticular, they had increased numbers of B-1 cells
than a complete block in B cell maturation, since the(B2201CD232IgD2/loCD431, Figure 3A), some of which
deficiency in mature follicular B cells in adult CD722/2are CD51 B-1a cells (Figure 3B), and a modest increase
mice was not as severe as in young CD722/2 mice. Itin the number of B cells with the phenotypic features of
took longer for CD722/2 newborn mice to reach a steady-marginal zone cells (IgMhiIgD2/loCD21hi) (data not shown).
state level of mature B cell accumulation in the spleenThe number of immature B cells (IgMhiIgD2/loHSAhiCD432
and to accumulate adult numbers of B cells in lymphCD21lo) was similar to that in control mice (data not
nodes (data not shown).shown).
Consistent with the findings in the spleen, CD722/2
mice had increased numbers of B-1 cells (Figure 3C) Adult CD722/2 Mice Have a Slower Rate of Generating
Mature Recirculating B Cellsand reduced numbers of conventional B-2 cells (CD231,
data not shown) in the peritoneal cavity. In summary, Although adult mice are capable of generating 2 3 107
new B cells every day (Osmond, 1991), only about 10%±CD722/2 mice had a reduction in mature, long-lived con-
ventional B-2 cells in the periphery and an expansion 20% of them are recruited into the mature recirculating
peripheral B cell pool (Allman et al., 1993). To determineof B-1 cells.
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Figure 3. Reduced Numbers of B Cells and Altered Distribution of B Cell Subpopulations in the Periphery of CD722/2 Mice
(A) Average absolute numbers of B cells in the spleen (n 5 20), mesenteric lymph nodes (MLN) (n 5 16), Peyer's patches (PP) (n 5 8), and
numbers of splenic CD231 follicular B cells (FO) (n 5 20) and B-1 cells (n 5 12) of 8- to 12-week-old wild-type and CD722/2 mice. (B)
Representative 5% probability contour profiles of spleen cells of wild-type and CD722/2 mice. Comparable numbers of splenocytes were
recovered from wild-type and mutant mice. Note the decreased frequency of follicular B cells and increased frequency of B-1 cells in the
spleen of mutant mice. (C) Representative 5% probability contour profiles of lymphocytes in the peritoneal cavity of wild-type and CD722/2
mice. Note the increased frequency of B-1 cells in the peritoneum of mutant mice. (D and E) Increased numbers of IgA-expressing and PNAhi
B cells in Peyer's patches and mesenteric lymph nodes of CD722/2 mice. B cells (B2201) from Peyer's patches and mesenteric (mes.) lymph
nodes of wild-type and CD722/2 mice were analyzed for expression of IgM and IgD. IgM2IgD2 B cells were further analyzed for their expression
of IgA and binding to PNA. Note the increased frequency of the IgM2/IgD2 fraction and the increased numbers of IgA-expressing and PNAhi
B cells in Peyer's patches and mesenteric lymph nodes of CD722/2 mice. Shown are 5% contour plots, and percentages of gated cells of
total cells within the plot are indicated.
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CD23 expression (Figure 4B). The reduction of CD231
B cells in CD722/2 mice was mainly in the IgMint fraction,
which is the more mature population. The CD231IgMhi
fraction, which is less mature, was not affected in
CD722/2 mice. Furthermore, reduced numbers of B2201
cells were found in lymph nodes of CD722/2 mice (Figure
4B) at day 13 after irradiation. We therefore conclude
that CD72 expression is important for normal B cell
development in both developing and adult mice.
Overexpression of BCL-2 Does Not Completely
Change the B Cell Developmental Defect
in CD722/2 Mice
Bcl-2 is an important regulator of B cell apoptosis/sur-
vival during development. To test whether enforced ov-
erexpression of this inhibitor of apoptosis negates the
effects on B cell development introduced by the deletion
of CD72, CD722/2 mice were crossed with Em-BCL-2-
22 transgenic mice, which express BCL-2 at all stages
of B cell development (Strasser et al., 1991).
Overexpression of BCL-2 led to equivalent accumula-
tion of B cells in the periphery of 4- to 6-week-old
CD722/2 and control mice and a partial correction of
the B cell maturation defect observed in CD722/2 mice.
However, mice lacking CD72 and overexpressing BCL-2
still had a reduction in the frequency of mature B cells
(CD231HSAlo, or CD231IgMint/hi, or IgD1IgMint/hi) and a
higher frequency of immature B cells (CD232HSAhi or
IgD2) in the spleen (Figure 5A). In the bone marrow,
overexpression of BCL-2 in CD722/2 mice led to a less
severe reduction in IgD1 cells, yet these mice still had
a higher frequency of immature B cells (IgM1IgD2) and
a slightly lower frequency of mature B cells, including the
more mature IgMintIgD1 population and the less mature
IgMhiIgD1 population, than CD72-expressing, BCL-2
transgenic controls (Figure 5B). Therefore, the B cell
developmental defect in CD722/2 mice is likely in part
a result of increased apoptosis blockable by enforced
expression of Bcl-2, but the maturation deficiency is not
Figure 4. Delayed B Cell Maturation in Young and Adult CD722/2 solely a result of increased apoptosis of B cells as they
Mice mature.
(A) Representative 5% probability contour profiles of spleen cells
from wild-type (1/1) and CD722/2 (2/2) mice of 4 weeks of age.
Hyperproliferation of CD722/2 B Cells In Vitro(B) Delayed generation of mature B cells in sublethally irradiated
Next, we determined whether the loss of CD72 affectsCD722/2 mice. Representative 5% probability contour profiles of
splenic B cells and cervical lymph node cells from wild-type and the ability of B cells to respond with proliferation to
CD722/2 adult mice 13 and 15 days after sublethal dosage of irradia- various stimuli. In particular, we tested the effects of
tion are shown. Plots of CD23 versus IgM of B2201 splenic B cells are lack of CD72 costimulation on the response to activation
shown. Percentages of CD23hiIgMint mature B cells and CD23hiIgMhi
via the B cell receptor by IgM cross-linking and on thetransitional B cells out of total splenic B cells are indicated. Plots
response to polyclonal stimulation by the mitogen lipo-of B220 versus CD3e of cervical lymph node cells from day 13
polysaccharide (LPS) (Figure 6A). To minimize subpopu-reconstituted mice are shown, and percentages of B2201 B cells
and CD31 T cells out of total live lymph node cells are indicated. lation differences, T cell±depleted splenic B cells from
adult CD722/2 and wild-type mice were purified through
Percoll gradient centrifugation, and resting B cells re-
covered from the interface of 60%±70% Percoll gradientwhether the alterations in the B cell compartments of
adult CD722/2 mice resulted from maturation defects were used for proliferation assays; these cells were
mostly mature CD231IgD1 cells from both wild-type andpresent only during ontogeny or whether such defects
extended into adulthood, we compared B cell replen- CD722/2 mice (Figure 6A). These purified resting splenic
B cells from CD722/2 mice showed increased prolifera-ishment of adult wild-type and CD722/2 mice at 13 and
15 days after sublethal irradiation. tive responses to low levels of IgM cross-linking in the
presence or absence of IL-4 and to stimulation with LPSFollowing irradiation, CD722/2 and control mice had
similar numbers of total B cells in the spleen. However, compared to wild-type controls. Increased proliferation
of B cells from CD722/2 mice was most prominent atmore of the B cells in the mutant mice were of the
immature phenotype, as demonstrated by their lack of suboptimal concentrations of F(ab9)2 anti-IgM and LPS
Immunity
500
6A, mutant B cells proliferated more upon BCR-FcgRIIB
co-cross-linking than wild-type controls. However, both
types of B cells showed a strong reduction in prolifera-
tion compared to stimulation with F(ab9)2 anti-IgM.
Therefore, CD72 expression is not necessary for the
FcgRIIB-mediated block in proliferation.
Altered In Vitro Ca21 Responses by CD722/2 B Cells
SHP-1 mutant B cells have an exaggerated intracellular
Ca21 response to antigen cross-linking (Cyster and
Goodnow, 1995). Given that CD72 associates with
SHP-1 (Adachi et al., 1998; Wu et al., 1998), the ability
of wild-type and mutant splenic B cells to increase their
levels of intracellular free Ca21 after IgM cross-linking
was examined. As shown in Figure 6B, Ca21 modulation
in B cells from CD722/2 mice was distinctively altered in
that the increase in [Ca21]i following surface IgM cross-
linking was more rapid in the mutant B cells. This pheno-
type was observed over a range of F(ab9)2 anti-IgM
concentrations used for stimulation. These data indicate
that CD72 negatively regulates the proximal Ca21 re-
sponse to BCR signaling.
Humoral Immune Responses
in CD722/2 Mice
Serum immunoglobulin (Ig) levels in nonimmunized mice
were determined to assess any functional alterations
the loss of CD72 might have on this in vivo steady-state
B cell function. At 2 months of age, CD722/2 mice had
a small but statistically significant increase in the level
of serum IgM compared to wild-type controls, whereas
the levels of all other isotypes were comparable (Figure
7A). To test whether B cells from CD722/2 mice could
mount normal humoral responses to T cell±dependent
and type 2 T cell±independent antigens, CD722/2 mice
and wild-type littermates were immunized with 2,4,6-
trinitrophenol-conjugated keyhole limpet hemocyanin
(TNP-KLH) or TNP-Ficoll. At 7 and 14 days after immuni-
zation, sera from these mice were assayed by TNP-
specific and isotype-specific ELISA to determine the
levels of antigen-specific IgM, IgG1, IgG2a, IgG2b, and
IgG3. Mice were rechallenged with TNP-KLH at day 21Figure 5. Overexpression of BCL-2 Does Not Completely Rescue
and bled at day 28 and day 35 to determine their abilitythe B Cell Maturation Defect in CD722/2 Mice
to mount a secondary antibody response. Despite theRepresentative 5% probability contour profiles of spleen and bone
marrow B cells from 5-week-old wild-type (1/1) and mutant (2/2) observed alterations in their B cell compartment, CD722/2
mice expressing Em-BCL-2-22 transgene. (A) CD23 versus HSA, mice showed normal T-independent responses except
CD23 versus IgM, and IgD versus IgM contour plots of B2201 splenic for a slightly stronger IgM response to TNP-Ficoll at day
B cells are shown. Percentages of CD231HSAlo mature B cells and 7 (Figure 7B). Overall, the T cell±dependent primary and
CD232HSAhi immature B cells; mature CD231IgMint or IgD1IgMint
secondary responses to TNP-KLH in CD722/2 mice werecells, transitional CD231IgMhi or IgD1IgMhi cells, and immature
also similar to those seen in wild-type controls (FiguresCD232IgMhi or IgD2IgMhi B cells out of total B2201 cells are indi-
cated. (B) IgD versus IgM contour plots of B2201 bone marrow B 7C±7F). Therefore, CD72 expression does not appear
cells are shown. Percentages of immature IgM1IgD2 B cells, transi- to be necessary for the induction of normal humoral
tional IgD1IgMhi B cells, and mature IgD1IgMint B cells out of total immune responses to T cell±dependent and T cell±inde-
bone marrow B cells are indicated. pendent antigens or for isotype switching. However,
CD72 plays some role in regulating IgM responses as
CD722/2 mice had a slightly higher level of serum IgMand gradually disappeared with increasing concentra-
and a stronger IgM T-independent response.tions of stimuli (data not shown). Thus, the data suggest
that CD72 is a negative regulator of activation-induced
B cell proliferation. To test whether CD72 is required for Discussion
negative signaling through Fc receptors, we analyzed B
cell proliferation in response to BCR-FcgRIIB co-cross- In this study, we demonstrate that lack of CD72, a B
cell surface protein that recruits and is a substrate forlinking using whole anti-IgM Abs. As shown in Figure
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Figure 6. Hyperproliferation and Enhanced Kinetics of Intracellular Ca21 Response of Splenic B Cells from CD722/2 Mice
(A) Hyperproliferation of splenic B cells from CD722/2 mice. T-depleted splenic B cells were purified through Percoll gradient centrifugation,
and IgD versus CD23 contour plots of resting B cells recovered from the 60%±70% interface and more activated B cells recovered from the
50%±60% interface are shown. Proliferative response of Percoll gradient purified resting splenic B cells (60%±70% interface) from wild-type
(1/1) and mutant (2/2) mice to various stimuli is shown. All assays were performed in triplicate, and standard deviations are shown. The
results shown are representative of six individual experiments. The open boxes represent the wild-type mice, and the closed boxes represent
the mutant mice. 1 or 5 IgM, 1 or 5 mg/ml F(ab9)2 goat anti-mouse polyclonal antibodies; 0.1 or 1 LPS, 0.1 or 1 mg/ml LPS; 2 or 10 whole, 2
or 10 mg/ml goat anti-mouse polyclonal whole antibodies. (B) Intracellular Ca21 response of splenic B cells from wild-type and CD722/2 mice
upon IgM cross-linking. Splenocytes from wild-type and CD722/2 mice stimulated with 5, 10, and 15 mg/ml of F(ab9)2 goat anti-mouse polyclonal
antibodies were examined by flow cytometry for [Ca21]i modulation. Indo-1 violet/blue ratio correlates with [Ca21]i level, and the mean indo-1
ratio was calculated for every 10 sec (sec) fraction. Representative plots from six experiments of indo-1 violet/blue ratio over time are shown.
The time of addition of stimuli is indicated by the arrow.
the tyrosine phosphatase SHP-1, affects the develop- velopment but rather affects the number or the kinetics
of the cells selected into the mature B cell pool. Consis-ment and the functional activation of B cells in vivo. The
most prominent effects of CD72 deficiency on B cell tent with the effect of CD72 deletion on immature B
cells, we found that normal B cells at this stage expressdevelopment were seen at the transition from the imma-
ture to mature B cell stage. Decreased numbers of ma- the highest level of CD72 compared to all other B cell
maturation stages (data not shown).ture B cells were found in the bone marrow and periphery
of CD722/2 mice. In both young and adult mice, there Lack of CD72 expression also affected the pre-B cell
compartment. This compartment (Hardy's fraction D,was ongoing delayed B cell maturation. Our data there-
fore provide direct evidence that CD72 plays an impor- Figure 2) was increased in size, and the ratio of immature
B cells to pre-B cells was reduced, suggesting that CD72tant role in the efficiency of this developmental transi-
tion, possibly by negatively regulating BCR signaling. might be important for the efficient transition from the
pre-B cell to the immature B cell stage. However, imma-However, mature B cells are found in CD722/2 mice,
albeit at reduced numbers, demonstrating that the lack ture B cells were present at relatively normal rather than
reduced numbers in the bone marrow of CD722/2 mice;of CD72 signaling does not completely block B cell de-
Immunity
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this could be the result of a combination of a relatively
decreased proportion of immature B cells from ineffi-
cient transition from the pre-B to immature B cell stage
and the opposite effect from inefficient transition from
the immature to mature B cell stage. Alternatively, the
accumulation of pre-B cells could also be a result of
increased or abnormal proliferation of pre-B cells, as
increased proliferation following BCR-stimulation was
seen in mature, CD722/2 B cells. It is conceivable that
CD72 could negatively regulate pre-BCR signaling.
Immature B cells express very low levels of Bcl-2
(Carsetti et al., 1995), rendering these cells exquisitely
sensitive to apoptosis induction. Data from transgenic
mouse models indicate that negative selection occurs
at this stage of B cell development (Goodnow et al.,
1995), facilitated in part by the lack of Bcl-2 expression.
Excessive signaling through the BCR in mature B cells
could also lead to their increased apoptosis as evi-
denced by CD222/2 mice, in which the reduction in ma-
ture recirculating B cells was secondary to their in-
creased turnover (Otipoby et al., 1996). The decrease in
the number of mature B cells in CD722/2 mice was par-
tially corrected by overexpression of Bcl-2, indicating
that the deficiency of mature B cells may result in part
from increased apoptosis of mature B cells or immature
B cells on their way to maturation. In support of this
interpretation, BrdU incorporation studies also showed
a slight increase in B cell turnover in the spleen of
CD722/2 mice (data not shown). However, the B cell
maturation defect was not fully reversed by overexpres-
sion of Bcl-2, suggesting that CD72 plays an additional
role in B cell maturation beyond regulation of cell death
of immature and/or mature B cells.
In contrast to the reduced numbers of mature conven-
tional B-2 cells found in CD722/2 mice, the mutant mice
had increased numbers of B-1 cells in the spleen and
peritoneal cavity. These data are reminiscent of findings
in a number of other gene-targeted mice that lack mole-
cules important in BCR signaling with divergent conse-
quences for B-1 and B-2 cell development. Our data
therefore provide further evidence that B-1 and B-2 cell
development is differently affected by signaling through
the BCR and its coreceptors and demonstrate that CD72
is one such coreceptor. Mice deficient in molecules that
negatively regulate BCR signaling, including SHP-1 (Sid-
man et al., 1986) and CD22 (O'Keefe et al., 1996; Sato
et al., 1996a), show an expansion of B-1 cells, whereas
mice deficient in several other molecules known to posi-
tively regulate BCR signaling, including the nonreceptor
tyrosine kinase Btk (Khan et al., 1995), the B cell surface
molecule CD19 (Engel et al., 1995; Rickert et al., 1995),
gens. Levels of TNP-specific IgM, IgG1, and IgG3 in CD722/2 mice
and wild-type littermates (n 5 10) at 7 and 14 days after immunization
with TNP-Ficoll are shown. (C±F) Humoral responses to T cell-
dependent antigens. Levels of TNP-specific IgM, IgG1, IgG2a,
IgG2b, and IgG3 in CD722/2 mice and wild-type littermates at 7 and
14 days after primary and secondary immunizations with TNP-KLH
(n 5 12) are shown. Statistical analyses were performed using Stat-
Figure 7. Humoral Immune Responses in CD722/2 Mice view 4.5 software (Abacus Concepts). P values were calculated
(A) Serum immunoglobulin (Ig) levels in 8-week-old nonimmunized using Unpaired t-test, and statistically significant differences (p ,
wild-type (1/1) and mutant (2/2) mice on 100% 129 background 0.05) between responses of wild-type and CD722/2 mice were
(n 5 10). (B) Humoral responses to type 2 T cell±independent anti- marked by an asterisk.
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the C3d complement receptor CD21 (Ahearn et al., and CD722/2 mice were masked by the use of a strong
adjuvant or by high doses of antigen.1996), and the signaling molecule Ig-a (Torres et al.,
At the molecular level, the negative regulatory function1996), all have various degrees of reduction in the num-
of CD72 could be exerted through the two ITIMs in itsber of B-1 cells (reviewed in Tedder et al., 1997). CD72
cytoplasmic tail. Upon phosphorylation of its ITIM mo-gene-targeted mice fall within the first group of mice,
tif(s), CD72 recruits (Adachi et al., 1998; Wu et al., 1998)therefore suggesting that CD72 negatively regulates
and serves as a substrate for the tyrosine phosphataseBCR signaling in vivo.
SHP-1 (Wu et al., 1998). The first ITIM sequence (5ITY-Our functional studies on B cells from CD722/2 mice
ADL10) has been shown to be critical for SHP-1 associa-strongly support such a conclusion. These B cells showed
tion, while the second (37LTYENV42) is capable of in vitroheightened, antigen-dose-dependent responses to in
binding with Grb2 (Wu et al., 1998). The potential associ-vitro stimulation. In particular, B cells from CD722/2 mice
ation of CD72 with Grb2 in vivo provides another mecha-proliferated at increased levels to various stimuli, includ-
nism by which CD72 might regulate downstream ef-ing BCR cross-linking and polyclonal activation through
fector proteins, since Grb2 binds to Sos, a guanineLPS, suggesting that CD72 might negatively regulate a
nucleotide exchange factor for Ras (Egan et al., 1993;common step in the pathway leading to B cell prolifera-
Li et al., 1993).tion. The proproliferative effects seen with anti-CD72
The phenotype of CD722/2 mice is similar to but moremAb treatment may be explained by mAb blocking of
subtle than that of mev mice, which express a catalyti-negative regulatory signals. Notably, the FcgRIIB-medi-
cally impaired form of SHP-1. Both types of mice haveated inhibitory pathway was still functional in CD722/2
an expansion of B-1 cells and a reduction of B-2 cellsmice, as CD722/2 B cells, like control B cells, were
(Sidman et al., 1986). Their B cells both mount an in-strongly inhibited in their proliferative response to stimu-
creased calcium response to BCR cross-linking (Cysterlation with whole anti-IgM Abs, which bind to both IgM
and Goodnow, 1995).and the FcgRIIB. Also consistent with a negative regula-
CD722/2 mice are also similar to CD222/2 micetory role for CD72, Ca21 flux, a very early signaling event
(O'Keefe et al., 1996; Otipoby et al., 1996; Sato et al.,after BCR cross-linking, was more rapidly induced in
1996a; Nitschke et al., 1997). CD22, a B cell coreceptor,CD722/2 mice following IgM cross-linking.
also contains ITIMs in its cytoplasmic tail and has beenThe difference in proliferation between purified resting
shown to associate with SHP-1 (Campbell and Klinman,splenic B cells from CD722/2 and wild-type mice was
1995; Doody et al., 1995; Law et al., 1996). Both CD72-mainly a result of loss of expression of CD72, since the
and CD22-deficient mice have a great reduction in ma-Percoll gradient-purified CD722/2 and CD721/1 resting
ture, recirculating B cells in the bone marrow, and their BB cells (60%±70% interface) used for these assays were
cells are hyperproliferative to LPS stimulation. However,phenotypically very similar (Figure 6A). In contrast, the
CD22 plays a larger role in regulating the intracellularaltered calcium response of CD722/2 splenic B cells
calcium response of B cells to BCR stimulation, ascould result, at least in part, from the altered compo-
CD222/2 B cells have a much greater calcium flux uponsition of B cell subpopulations, since the intracellular
low-level BCR cross-linking, while CD72 plays a morecalcium assay measured the calcium response of total
important role in early B cell development. CD22 is asplenic B cells. Calcium mobilization occurs more
negative regulator of antigen receptor signaling, and itsquickly and continues for a longer time in marginal zone
increased expression at the mature B cell stage may(MZ) B cells than in follicular B cells and newly formed
serve to raise the antigen concentration threshold re-B cells (Oliver et al., 1997), and the CD722/2 mice had
quired for B cell triggering. CD72 is also a negativea slightly higher percentage of MZ cells and a lower
regulator of BCR signaling; however, its reduced expres-percentage of follicular B cells. Furthermore, the in-
sion at the mature B cell stage may be critical for thecreases in the steady-state levels of serum IgM and the
regulation of mature B cell activation. Moreover, CD22
increase in the IgM-response to TNP-Ficoll might also
and CD72 may be functionally redundant in some as-
be explained, at least in part, by the increased numbers
pects of in vivo function, as the phenotype of mice defi-
of B-1 cells and MZ cells found in CD722/2 mice, since cient in either one of these proteins was not as severe
B-1 cells have been shown to be largely responsible for as mev mice. Experiments are in progress to study the
basal serum Igs and to be critical for T cell±independent potential redundancy in CD722/2 CD222/2 double mu-
type 2 responses (Kantor and Herzenberg, 1993). In ad- tant mice.
dition, MZ B cells have been proposed to have an impor- Finally, the phenotype of CD722/2 mice closely resem-
tant role in the response to T cell±independent type 2 bles that of the tyrosine kinase Lyn2/2 mice (Hibbs et
antigens (Oliver et al., 1997). al., 1995; Nishizumi et al., 1995; Wang et al., 1996). Like
Our findings of heightened B cell responsiveness in CD722/2 mice, Lyn2/2 mice have greatly reduced num-
vitro are in apparent contrast to the normal levels of bers of mature recirculating B cells in the bone marrow
serum Ig and the normal in vivo responses to immuni- and in the periphery. Like young CD722/2 mice, young
zation in CD722/2 mice. However, CD722/2 mice had Lyn2/2 mice also show delayed B cell maturation and
increased numbers of germinal center and isotype- Lyn mutant B cells are hyperresponsive to IgM cross-
switched B cells in Peyer's patches and lymph nodes, linking and LPS stimulation (Wang et al., 1996). The
suggesting heightened steady-state B cell activation in similarity of these mice suggests that Lyn might be in
vivo. Furthermore, we noted increased numbers of acti- the signaling pathway of CD72. Consistent with this,
vated and decreased numbers of resting splenic B cells CD72 is phosphorylated by Lyn tyrosine kinase in vitro
in CD722/2 mice. It is possible that differences in in vivo (Adachi et al., 1998). Lyn mutant mice produce autoanti-
bodies and develop glomerulonephritis, suggestive ofresponses to antigen immunization between wild-type
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APC, and anti-IgD PE were purchased from Southern Biotechnologysystemic lupus erythematosus (SLE) (Hibbs et al., 1995;
Associates. All other antibodies were purchased from PharMingen.Nishizumi et al., 1995). We have not seen evidence of
Samples were analyzed on a modified Vantage (Beckton Dickinson)autoimmune diseases in CD722/2 mice to date.
equipped with an Argon laser (488 nm) and a dye laser (595 nm).
In summary, by generating CD722/2 mice, we have For the analysis of bone marrow samples, eight-color FACS analy-
shown that CD72 plays a nonredundant role in B cell sis was performed using the following antibodies: anti-CD3 Cascade
Blue (CB) (mAb 2C11); anti-CD4 CB (GK.1.5); anti-CD8 CB (53-6.7);development and function. Loss of CD72 leads to a
anti-macrophage antigen F4/80 CB; anti-BP-1 FITC (6C3); anti-CD43reduction in mature conventional B-2 cells and an
phycoerythrin (PE) (S7); anti-B220 Cy5-PE; anti-IgD Cy7-PE (1126);expansion of B-1 cells similar to that seen in mice defi-
anti-CD24 TR (30. F1); anti±stem cell antigen AA4.1 APC; and anti-cient in other proteins that negatively regulate BCR sig-
IgM Cy7-APC (331). The antibodies were purified from hybridoma
naling. On mature B cells, the accentuated signaling supernatant and conjugated as outlined (Hardy, 1986; Roederer et
resulting from CD72-deficiency lowers the threshold for al., 1996). For eight-color analysis, a custom-built triple laser FACS
was used as described previously (Roederer et al., 1997). Data analy-B cell activation.
sis was performed using the FlowJo software (Treestar).
Experimental Procedures
Cell Proliferation Assays
Splenocytes from 8- to 12-week-old mice were depleted of T cellsCloning of the CD72 Gene and Construction
by incubating with an antibody cocktail of Thy1.2 (3HO12), CD4of the CD72 Targeting Vector
(GK1.5), and CD8 (3.155) monoclonal antibodies, followed by T cellA 14.2 kb CD72 genomic clone from the 129 mouse strain was
lysis with 3±4 week rabbit complement (Pel-Freez). Resting B cellsisolated by screening a 129/SV/EV genomic library (Stratagene) with
were separated from macrophages, dead cells, and debris by cen-two probes derived from the CD72 cDNA sequence. Based on the
trifugation in a discontinuous Percoll gradient of 50%, 60% andsequence information of the 8.5 kb CD72 gene from C57L mice
70% and collected from the 60%±70% interface. 2 3 105 purified B(Ying et al., 1995), restriction mapping analysis was performed on
cells were plated in each well in 96-well flat-bottom plates in com-the 14.2 kb clone. This genomic clone was shown to contain 7.1 kb
plete RPMI medium containing 5% FCS and b-mercaptoethanolof CD72 59 flanking sequence and 7.1 kb of sequence containing
(5 3 1025 M). B cells were stimulated with indicated concentrationsall the nine exons and eight introns of CD72 (Figure 1A). The targeting
of affinity-purified F(ab9)2 goat anti-mouse IgM antisera (Jacksonstrategy was to disrupt the minimal promoter and the cytoplasmic
Immune Research Laboratories), with or without 10 ng/ml IL-4, lipo-and transmembrane domains of CD72. To construct the CD72
polysaccharide (Sigma), or affinity-purified whole Ig goat anti-mouseknockout allele, the 2.1 kb fragment containing exons I, II, III (encod-
IgM (Jackson Immune Research Laboratories). One microcurie ofing the cytoplasmic tail), and exon IV (encoding the transmembrane
[3H]-thymidine was added for the last 6 hr of a 48 hr culture. Cellsdomain) sequences of CD72 was replaced with the pGK-MC1-neo
were harvested, and [3H]-thymidine uptake was measured.cassette. Therefore, the neo cassette was flanked with 6.9 kb CD72
59 homologous sequence and 5.3 kb 39 homologous sequence. The
Immunizations and Serum Antibody AssayspGK-tk cassette was then inserted upstream of the 6.9 kb CD72 59
Wild-type and CD722/2 mice of 8 weeks of age with 100% 129flanking sequence. The linearized targeting plasmid DNA was used
genetic background were prebled and immunized intraperitoneallyto transfect the E14.1 ES cells by electroporation. After double-
with either TNP-KLH (100 mg) (TNP28-KLH, Biosearch Technologies),selection with G418 and gancyclovir, 150 colonies were screened
with RIBI adjuvant (RIBI ImmunoChem Research), or with TNP-Ficollfor homologous recombination of the CD72 targeted allele by South-
(20 mg) (Biosearch Technologies) in PBS. RIBI adjuvant was usedern blot analysis and PCR using one primer derived from the neo
according to manufacturer's instructions. Mice were bled at day 7sequence and the other primer derived from CD72 sequence down-
and day 14 after primary immunization with TNP-KLH and TNP-stream of the 5.3 kb CD72 39 homologous sequence within the
Ficoll. Mice were rechallenged with TNP-KLH with RIBI adjuvant attargeting plasmid. Two clones with homologous recombination were
day 21 and bled at day 28 and day 35 to assess the secondaryidentified.
response. Sera were collected, and the anti-TNP antibodies were
determined by TNP- and isotype-specific ELISA. In brief, ELISA
Generation, Screening, and Breeding of CD72-Deficient Mice plates were coated with TNP-BSA (10 mg/ml) (TNP31-BSA, Biosearch
10±15 ES cells from the two CD72 knockout clones were injected into Technologies) and blocked with BSA (1%) and Tween-20 (0.05%).
3.5-day blastocysts harvested from C57BL/6 mice. The blastocysts Sera were serially diluted in triplicate and detected with horseradish
were transferred to pseudopregnant C57BL/6 3 CBA F1 foster peroxidase-conjugated rabbit anti-mouse isotype-specific antisera
mothers. Male chimera were crossed with C57BL/6 mice, and germ- (Southern Biotechnology Associates).
line transmission was scored by agouti coat color. Germline trans-
mission of CD72-targeted allele was further assayed by Southern Calcium Mobilization Assay
blot and PCR analysis. Mice with the CD72 null allele were either To monitor changes in [Ca21]i, splenocytes were resuspended at
bred with 129/SV/EV mice to establish a CD722/2 line with 100% 107 per ml in RPMI 1640 medium containing 5% FCS (fetal calf
129 background or backcrossed to C57BL/6 up to eight generations serum) and 10 mM HEPES, loaded with 1 mM indo-1/AM ester (Mo-
to obtain a CD722/2 line with C57BL/6 background. lecular Probes) for 45 min at 378C, and stained with anti-FITC-CD3
(145-2C11, PharMingen) for the last 5 min at 378C. Cells were washed
Flow Cytometric Analysis and resuspended at 2 3 106 per ml in the same RPMI medium. The
Single-cell suspensions were prepared from mouse spleen, cervical, ratio of indo-1 violet/blue of CD32 B cells was analyzed by flow
or mesenteric lymph nodes, and Peyer's patches. Bone marrow cytometry using FACSTAR (Beckton Dickinson). Data were collected
cells were obtained from one tibia and one femur. Peritoneal cavity for 45 sec to establish baseline violet/blue ratios; cells were then
cells were collected by flushing the peritoneal cavity with PBS 1 stimulated with anti-IgM F(ab9)2, and data were collected for a total
2% FCS (fetal calf serum). One million cells of the various tissues of 5 min.
tested were stained with the following antibodies: anti-CD3e (145-
2C11), anti-CD4 (RM4-5), anti-CD8a (53-6.7), anti-CD5 (53-7.3), anti- Sublethal Irradiation of Mice
CD43 (S7), anti-B220 (RA3-6B2), anti-CD19 (6D5), anti-CD21 (7G6), Wild-type and mutant mice on a C57BL/6 background were sub-
anti-CD22 (Cy34.1), anti-CD23 (B3B4), anti-CD24 (HSA, M1-69), jected to 500 rad whole body irradiation. Self-reconstitution of pe-
F(ab9)2 anti-IgM (polyclonal goat anti-mouse), and anti-IgD (11-26) ripheral B cells was analyzed 13 and 15 days after irradiation.
conjugated with FITC (fluorescein), R-PE (R-phycoerythrin), TR
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